IGF1 and prostate carcinoma: We analyzed the association of serum concentrations of 25(OH)D with prostate cancer within strata of high and low serum concentrations of IGF analytes within the finasteride (Table S2, Supplementary) and placebo (Table S3, Supplementary) arms.